Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”

Moon Haeng Hur, Yoon Jun Kim

Clin Mol Hepatol. 2025;31(1):e93-e95. Published online November 6, 2024

DOI: https://doi.org/10.3350/cmh.2024.0943

View: 1103 Download: 44

Letter to the Editor

Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Hang Li, Hua Lu, Xi-Ping Shen, Xiao-Song Li

Clin Mol Hepatol. 2025;31(1):e3-e4. Published online October 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0832

View: 1150 Download: 51 Crossref: 1

Editorial

Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”

Jin Hyoung Kim, Gun Ha Kim, Dong Il Gwon

Clin Mol Hepatol. 2024;30(4):659-662. Published online July 17, 2024

DOI: https://doi.org/10.3350/cmh.2024.0516

View: 1649 Download: 85

Original Article

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee

Clin Mol Hepatol. 2016;22(1):160-167. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.160

View: 12655 Download: 203 Web of Science: 85 Crossref: 74

4

A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy

Ik Yoon, M.D., Hyung Joon Yim, M.D., Jin Nam Kim, M.D., Sun Min Park, M.D., Jeong Han Kim, M.D., Seung Hwa Lee, M.D. Hwan Hoon Chung, M.D. Hong Sik Lee, M.D., Sang Woo Lee, M.D., Jai Hyun Choi, M.D.

Clin Mol Hepatol. 2009;15(1):90-95. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.90

View: 4988 Download: 45 Crossref: 1

3

Efficacy of Transarterial Chemolipiodolization with or without 3-Dimensional Conformal Radiotherapy for Huge HCC with Portal Tumor Thrombosis

Chan Ran You, M.D., Jeong Won Jang, M.D., Seok Hui Kang, M.D., Si Hyun Bae, M.D., Jong Young Choi, M.D., Seung Kew Yoon, M.D., Ihl Bhong Choi, M.D. Dong Hoon Lee, M.D. Ho Jong Chun, M.D. Byung Gil Choi, M.D.

Clin Mol Hepatol. 2007;13(3):378-386. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.378

View: 5350 Download: 55 Crossref: 13

1 |

Viewed By 11971	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7500	MAFLD: How is it different from NAFLD?
Viewed By 6574	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5752	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 5380	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 355	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 331	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 223	MAFLD: How is it different from NAFLD?
Cited By 114	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 110	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search